{"id":"https://openalex.org/W4229901930","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-014","title":"Abstract LB-014: Antibody targeting soluble NKG2D ligand sMIC sensitizes metastatic prostate tumor and other MIC+ tumors to PD1/PD-L1 blockade therapy in pre-clinical models","display_name":"Abstract LB-014: Antibody targeting soluble NKG2D ligand sMIC sensitizes metastatic prostate tumor and other MIC+ tumors to PD1/PD-L1 blockade therapy in pre-clinical models","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4229901930","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-014"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-lb-014","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-014","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-lb-014","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101919644","display_name":"Jennifer D. Wu","orcid":"https://orcid.org/0000-0002-8925-268X","observed_orcids":["https://orcid.org/0000-0002-8925-268X"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer D. Wu","raw_affiliation_strings":["1Northwestern University, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Northwestern University, Chicago, IL;","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100434992","display_name":"Jinyu Zhang","orcid":"https://orcid.org/0000-0002-9200-5348","observed_orcids":["https://orcid.org/0000-0002-9200-5348"]},"institutions":[{"id":"https://openalex.org/I119443389","display_name":"East Tennessee State University","ror":"https://ror.org/05rfqv493","country_code":"US","type":"education","lineage":["https://openalex.org/I119443389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinyu Zhang","raw_affiliation_strings":["2East Tennessee State University, Tennessee, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2East Tennessee State University, Tennessee, TN","institution_ids":["https://openalex.org/I119443389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036428110","display_name":"Pablo Saenz-Lopez Larrocha","orcid":"https://orcid.org/0009-0002-3097-3156","observed_orcids":["https://orcid.org/0009-0002-3097-3156"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo Larrocha","raw_affiliation_strings":["1Northwestern University, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Northwestern University, Chicago, IL;","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022422325","display_name":"Payal Dhar","orcid":"https://orcid.org/0000-0001-5379-8675","observed_orcids":["https://orcid.org/0000-0001-5379-8675"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Payal Dhar","raw_affiliation_strings":["1Northwestern University, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Northwestern University, Chicago, IL;","institution_ids":["https://openalex.org/I111979921"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"LB","last_page":"014"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-nkg2d-ligands","display_name":"soluble NKG2D ligands","score":0.843999981880188},{"id":"https://openalex.org/keywords/smic","display_name":"SMIC","score":0.906000018119812},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.796999990940094},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.9359999895095825},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.8190000057220459},{"id":"https://openalex.org/keywords/antibody-therapy","display_name":"antibody therapy","score":0.5360000133514404},{"id":"https://openalex.org/keywords/nk-cell-infiltration","display_name":"NK cell infiltration","score":0.9269999861717224},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.875},{"id":"https://openalex.org/keywords/cd28-costimulation","display_name":"CD28 costimulation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.5740000009536743},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.9179999828338623}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7350577116012573},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6904834508895874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6533133387565613},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6440600156784058},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5814079642295837},{"id":"https://openalex.org/C2778867473","wikidata":"https://www.wikidata.org/wiki/Q17544382","display_name":"NKG2D","level":4,"score":0.5328719019889832},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5256506204605103},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4961114823818207},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4370434284210205},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42489010095596313},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4207160472869873},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3653706908226013},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3419191241264343},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26506465673446655},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19327953457832336},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13589969277381897},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-lb-014","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-014","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-lb-014","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3012048262","https://openalex.org/W2567253817","https://openalex.org/W3034092171","https://openalex.org/W4313373440","https://openalex.org/W2887405870","https://openalex.org/W6921002391","https://openalex.org/W2547673344","https://openalex.org/W2593010745","https://openalex.org/W4393071769","https://openalex.org/W6920568355"],"abstract_inverted_index":{"Abstract":[0],"Targeting":[1],"programmed":[2],"cell":[3,169,173,216],"death-1":[4],"(PD-1)":[5],"has":[6],"produced":[7],"a":[8,101,128,205,246],"survival":[9,22],"benefit":[10,23],"for":[11,250,297],"patients":[12],"diagnosed":[13],"with":[14,181],"many":[15,52],"types":[16],"of":[17,35,88,141,157,192,199,232,245,293],"malignancies.":[18],"However,":[19],"the":[20,33,51,71,89,114,138,155,190,200,294],"clinical":[21,72],"in":[24,78,106,223,287],"metastatic":[25,37,120,143,251,276],"prostate":[26,38,82,121,144,158,195,225,252,277],"cancer":[27,39,83,234,253],"is":[28,40,104],"only":[29],"marginal":[30],"to-date.":[31],"Currently,":[32],"understanding":[34],"why":[36],"resistant":[41],"to":[42,47,58,69,74,123,160,283],"PD-1":[43,59,124],"blockade":[44,60,77,125,162,207,285],"therapy":[45,286],"remains":[46],"be":[48],"defined.":[49],"Among":[50],"factors":[53],"that":[54,103,116,135,148],"negatively":[55],"impact":[56],"response":[57,73,156],"treatment,":[61],"tumor-derived":[62],"soluble":[63,91,94,271],"NKG2D":[64,92,183,272],"ligands":[65],"have":[66],"been":[67],"reported":[68],"hinder":[70],"immune":[75],"checkpoint":[76],"melanoma":[79],"patients.":[80],"Metastatic":[81],"cells":[84,180],"release":[85],"high":[86],"levels":[87],"circulating":[90],"ligand,":[93],"MHC":[95],"I":[96],"Chain":[97],"related":[98],"molecule":[99,102],"(sMIC),":[100],"absent":[105],"classical":[107],"rodent":[108],"tumor":[109,196,226,278],"model.":[110],"Here,":[111],"we":[112,146],"tested":[113],"hypothesis":[115],"targeting":[117,151,165,202,270],"sMIC":[118,152,166,203,274],"sensitizes":[119,275],"tumors":[122,159,282],"therapy.":[126,163],"Using":[127],"well-described":[129],"double":[130],"transgenic":[131],"TRAMP/MIC":[132],"mouse":[133],"model":[134],"closely":[136],"resembles":[137],"onco-immune":[139],"dynamics":[140],"human":[142],"cancer,":[145],"demonstrate":[147],"an":[149],"antibody":[150,201],"significantly":[153],"enhances":[154],"PD-1/PD-L1":[161,206],"Mechanistically,":[164],"enriches":[167],"NK":[168,211],"and":[170,184,188,204,212,229,241,254,279],"CD8":[171,178,214],"T":[172,179,215],"infiltration":[174],"into":[175],"tumors,":[176],"equips":[177],"enhanced":[182],"CD28":[185],"dual":[186],"co-stimulation,":[187],"increases":[189],"expression":[191],"PD-L1+":[193],"on":[194],"cells.":[197],"Combination":[198],"cooperatively":[208],"augments":[209],"intra-tumoral":[210],"antigen-specific":[213],"anti-tumor":[217],"immunity.":[218],"These":[219],"findings":[220],"were":[221],"validated":[222],"syngeneic":[224],"transplant":[227],"models":[228,231,289],"other":[230,233,255,280],"types.":[235],"Our":[236],"pre-clinical":[237,288],"study":[238],"provides":[239],"proof-of-concept":[240],"uncovered":[242],"novel":[243],"mechanisms":[244],"viable":[247],"combination":[248],"immunotherapy":[249],"MIC+":[256,281],"cancers.":[257],"Citation":[258],"Format:":[259],"Jennifer":[260],"D.":[261],"Wu,":[262],"Jinyu":[263],"Zhang,":[264],"Pablo":[265],"Larrocha,":[266],"Payal":[267],"Dhar.":[268],"Antibody":[269],"ligand":[273],"PD1/PD-L1":[284],"[abstract].":[290],"In:":[291],"Proceedings":[292],"American":[295],"Association":[296],"Cancer":[298,312],"Research":[299],"Annual":[300],"Meeting":[301],"2019;":[302],"2019":[303],"Mar":[304],"29-Apr":[305],"3;":[306],"Atlanta,":[307],"GA.":[308],"Philadelphia":[309],"(PA):":[310],"AACR;":[311],"Res":[313],"2019;79(13":[314],"Suppl):Abstract":[315],"nr":[316],"LB-014.":[317]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-05-11T00:00:00"}